Report Summary: Best Practices in Crisis Management & Business Continuity for BioPharma Manufacturing and Supply Chain Operations
For report summary, click "Add to Cart" on right.
Today’s pharma and medical device industries operate in a truly global market environment.
Now, in the wake of major devastating events (such as the earthquake, tsunami, and partial nuclear meltdown in Japan last year), leading healthcare organizations have moved quickly to ensure their global supply chains and manufacturing operations are capable of sustaining sudden – and potentially ruinous – disruptions and disasters.
This new Best Practices, LLC report examines how world-class companies optimize their Business Continuity and Crisis Management groups and how their response plans fare when faced with major disasters or operating disruptions.
This report is designed to help companies develop an evidence-based understanding of how other companies plan, prevent, prepare and respond to threats to their supply chains and operations – both to keep employees safe and ensure continued production and long-term viability.
The study includes two segments: a Large Healthcare Company segment and a Small Healthcare Company and Clinic segment.
Business Operations > Supply Chain Management d
Industries Profiled:
Biotech; Pharmaceutical; Medical; Manufacturing; Medical Device; Health Care; Diagnostic; Consumer Products; Chemical; Laboratories
Companies Profiled:
Amgen; Alameda County Medical Center; Insight Adhesives Research; Siemens Medical; Nypro; GlaxoSmithKline; Abbott; UCB Pharma; Genzyme; Shire; Fibrogen; Terumo Corporation; Sanofi; Merck; Ipsen; Amylin; Lilly; Boehringer Ingelheim; Boston Scientific; Bayer Healthcare; Johnson & Johnson; Genentech; EMD Serono; Ben Venue Laboratories; Janssen; Smith & Nephew; Grifols; MedImmune
Study Snapshot
The report is based on the insights of 33 Business Continuity (BC) leaders from 29 national and global health care organizations. In addition, selected executives provided qualitative insights through deep-dive interviews and “lessons learned” observations.
Back to Top
Sample Key Findings
Emergency Response Training Is Essential For Fast Response – But Training Occurs Sporadically at Most Companies: More than 60% of companies conduct emergency response training once or twice a year – or not at all. Training frequency goes hand and hand with response effective-ness. This seems an Achilles’ heel for many companies. Less than 1/3 of companies train monthly or quarterly.
During Major Events: Communicate Early & Often: Active communication is a critical tool for managing through crisis. Daily briefings are advocated by 86% of the benchmark class and sharing of lessons learned is used by 71% of companies.
The Supply Chain Can Be Disrupted in Many (Unexpected) Ways: Natural disasters are not the only threat to a company’s supply of medical products to the market and its customers. Disruptions range widely from parts to material purity to manufacturing. Small disruptions can disrupt or shut down supply chains.
Back to Top
Related Research:
Supply Chain Management Best Practices
 |
Supply Chain performance remains a key factor in corporate competitiveness as organizations improve, refine and adopt build-to-order/ mass customization programs, vendor managed inventory and othe productive initiatives... (ID OP-87)
Companies Profiled: DaimlerChrysler, Dana Corporation, Dell Computer, Eastman Kodak, more ...
Price: $3180.00 Free Excerpt Available
| |
|